tm logo
METAPHORE BIOTECHNOLOGIES
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 12 Mar 2024

Last Applicant/ Owned by

55 CAMBRIDGE PARKWAY, SUITE 800E

CAMBRIDGE

MA

02142

Serial Number

97728237 filed on 22nd Dec 2022

Registration Number

N/A

Correspondent Address

Christina M. Licursi

WOLF, GREENFIELD & SACKS, P.C.

600 ATLANTIC AVENUE

BOSTON, MA 02210-2206

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"'BIOTECHNOLOGIES'"

METAPHORE BIOTECHNOLOGIES

Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and scientific and technological research relating to drug development; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical, andRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and scientific and technological research relating to drug development; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical, and genomic research; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; providing temporary use of online non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research

Class [009]
Computer & Software Products & Electrical & Scientific Products


Downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical, and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research

Class [005]
Pharmaceutical Products


Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for use in the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, obesity, endocrine diseases and disorders, gastrointestinal diseases and disorders, hepatic diseases and disorders, nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, ocular diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders

Mark Details


Serial Number

No 97728237

Mark Type

No Service Mark

Attorney Docket Number

No F08932000100

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Mar 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16th Jan 2024PUBLISHED FOR OPPOSITION
16th Jan 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27th Dec 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13th Dec 2023APPROVED FOR PUB - PRINCIPAL REGISTER
09th Dec 2023TEAS/EMAIL CORRESPONDENCE ENTERED
08th Dec 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
08th Dec 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
27th Sep 2023NON-FINAL ACTION WRITTEN
27th Sep 2023NON-FINAL ACTION E-MAILED